Stannic oxide in its pure form is an n‐type wide‐bandgap semiconductor. Its electrical conduction results from the existence of point defects (native and foreign atoms) which act as donors or acceptors. Some unique properties of
SnO2
make the material useful for many applications; therefore, increasing attention is being paid to studies on this oxide, especially on the methods of preparation, and its electrical and optical properties. The purpose of this series is to provide a general up‐to‐date review of the investigations carried out and to help identify important areas for further studies. The first part was concerned with the preparation and defect structure of single crystals, sintered polycrystalline samples, and thin films, and in the second part we reviewed the electrical properties of these materials. In this part we discuss the optical properties of
SnO2
single crystals and films. This concludes our review of the physical properties of
SnO2
materials.
Commercially available MOSFETs, Thomson and Nielsen TN502-RD, were evaluated for suitability as an entrance dose in vivo dosimeter for 6MV and 10MV. Detector response was normally distributed around a mean (skewness=-0.01±0.24, kurtosis=-0.09±0.48) with a mean of 110.6 mV/Gy, with a standard deviation of 2.4% at 0.86 Gy. The standard deviation of readings increased with decreasing dose and increased at a rate greater than inverse square. The linearity coefficient was 0.9999. No significant dependence on angle, field size, dose rate, energy or time was observed. As such, they would be useful for entrance dose in vivo dosimetry. With a custom made build up cap corrections were required for field size, wedge, beam energy and tray factors, showing that build up cap design is an important consideration for entrance dose in vivo dosimetry using MOSFETs.
Thomson and Nielsen TN-502 RD MOSFETs were used for entrance dose in vivo dosimetry for 6 and 10 MV photons. A total of 24 patients were tested, 10 breast, 8 prostate, 5 lung and 1 head and neck. For prostates three fields were checked. For all other plans all fields were checked. An action threshold of 8% was set for any one field and 5% for all fields combined. The total number of fields tested was 56, with a mean discrepancy of 1.4% and S.D. of 2.6%. Breasts had a mean discrepancy of 1.8% and S.D. of 2.8%. Prostates had a mean discrepancy of 1.3% and S.D. of 2.9%. For 3 fields combined, prostates had a mean of 1.3% and S.D. of 1.8%. These results are similar to results obtained with diodes and TLDs for the same techniques.
The ideal electroretinography (ERG) electrode does not exist. In deciding which electrode should be used in clinical practice the capacity to provide reproducible waveforms, maximal amplitudes and minimal irritation to the patient's eyes are the most important characteristics. This study tested two patient friendly electrodes, the gold foil (CH Electrodes, UK) and the H-K loop (Avanta, Slovenia). Seventeen normal volunteers were subjected to three standard measurements namely flash ERGs under photopic and scotopic conditions and the transient pattern ERG (PERG). Each test followed the guidelines set by the International Society for Clinical Electrophysiology of Vision (ISCEV). It was found that the mean values of the flash ERG a and b wave amplitudes and the PERG P50 and N95 amplitudes from the gold foil electrodes were approximately a factor of two larger than those from the H-K loop. In addition most of the subjects (13/17) felt less discomfort with the gold foil electrodes. We reached the conclusion that gold foil electrodes are the electrode of choice because they provide good patient comfort, reasonably high amplitudes and relatively reproducible results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.